Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 13,007,586
- Share change
- -255,931
- Total reported value
- $31,748,000
- Price per share
- $2.42
- Number of holders
- 17
- Value change
- -$644,938
- Number of buys
- 7
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
4.6%
|
5,940,796
|
$23,941,000 | — | 30 Sep 2020 | |
| TPG Group Holdings (SBS) Advisors, Inc. |
13F
|
Company |
3.8%
|
4,824,883
|
$19,444,000 | — | 30 Sep 2020 | |
| Omega Fund Management, LLC |
13F
|
Company |
1.1%
|
1,375,907
|
$5,545,000 | — | 30 Sep 2020 | |
| FMR LLC |
13F
|
Company |
0.62%
|
792,700
|
$3,195,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
133,215
|
$537,000 | — | 30 Sep 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
100,000
|
$403,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
49,077
|
$197,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
22,118
|
$89,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
11,414
|
$46,000 | — | 30 Sep 2020 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
10,000
|
$40,000 | — | 30 Sep 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,407
|
$6,000 | — | 30 Sep 2020 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 30 Sep 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
179
|
$1,000 | — | 30 Sep 2020 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q4 2020
As of 31 Dec 2020,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,007,586 shares.
The largest 10 holders included
NEA Management Company, LLC, TPG Group Holdings (SBS) Advisors, Inc., Omega Fund Management, LLC, FMR LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and CANADA PENSION PLAN INVESTMENT BOARD.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
13
Q4 2020 holders
17
Holder diff
4
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.